meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.[1][2] It is the racemic form of the sympathomimetic drug metaraminol.
Clinical data | |
---|---|
Other names | m-hydroxypropadrine m-hydroxyphenylpropanolamine α-methyl-m-octopamine 3,β-dihydroxyamphetamine 3,β-dihydroxy-α-methylphenethylamine |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C9H13NO2 |
Molar mass | 167.208 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 106. ISBN 978-0-412-46630-4. Retrieved 24 April 2012.
- ^ Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. 15 January 2013. p. 2110. ISBN 978-0-8155-1526-5. Retrieved 24 April 2012.